Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    New therapies for allergic rhinitis
    David F. Graft, MD
    Cleveland Clinic Journal of Medicine March 2000, 67 (3) 165-168;

    Nearly one fourth of Americans have allergic rhinitis. Newer medications are more effective and have fewer side effects.

  • You have access
    Adjunctive medical therapy for acute coronary syndromes
    Mark Robbins, MD, Joel P. Reginelli, MD and Gary S. Francis, MD
    Cleveland Clinic Journal of Medicine March 2000, 67 (3) 205-213;

    Aspirin, nitrates, beta-blockcrs, ACE inhibitors, statins, and intraaortic balloon pumps all have important roles.

  • You have access
    Primary pulmonary hypertension: Update on pathogenesis and novel therapies
    Alejandro C. Arroliga, MD, Raed A. Dweik, MD, F. J. Takao Kaneko, MD and Serpil C. Erzurum, MD
    Cleveland Clinic Journal of Medicine March 2000, 67 (3) 175-190;

    Research into biochemical derangements, and new therapies that prolong survival.

  • You have access
    On this we agree: The value of healthy debate in medicine
    John D. Clough, MD
    Cleveland Clinic Journal of Medicine March 2000, 67 (3) 152;

    The debate on dyspepsia on page 214 illustrates the value of healthy controversy.

  • You have access
    How new technology is changing mammography and breast cancer management
    Gilda Cardenosa, MD, MS, William A. Chilcote, MD, Mary A. Barry, RN, Christine A. Quinn, MD and Mary G. Foglietti, RN
    Cleveland Clinic Journal of Medicine March 2000, 67 (3) 191-202;

    Improved detection now allows a tailored approach to abnormal findings.

  • You have access
    Is there an advantage to combination therapy with ACE inhibitors and angiotensin II-receptor blockers?
    Donald G. Vidt, MD
    Cleveland Clinic Journal of Medicine February 2000, 67 (2) 89-91;

    Theoretic reasons and small studies suggest the two types of drugs may be useful in combination, but a definitive answer awaits the results of larger studies.

  • You have access
    Psoriasis: A clinical update on diagnosis and new therapies
    Charles Camisa, MD
    Cleveland Clinic Journal of Medicine February 2000, 67 (2) 105-119;

    A framework for recognizing the many forms of psoriasis and a logical approach to therapy, which now includes, in severe cases, powerful immunosuppressive drugs.

  • You have access
    Glycoprotein Ilb/IIIa inhibitors in acute coronary syndromes
    Matthew T. Roe, MD, Shelly K. Sapp, MS and A. Michael Lincoff, MD
    Cleveland Clinic Journal of Medicine February 2000, 67 (2) 131-140;

    These potent antiplatelet agents constitute a breakthrough, hut questions remain about their safety, cost-effectiveness, and proper empiric use. With an illustration explaining the paradoxical prothrombotic effect of fibrinolytic drugs.

  • You have access
    Brain metastases: Presentation, evaluation, and management
    Mark A. Chidel, MD, John H. Suh, MD and Gene H. Barnett, MD
    Cleveland Clinic Journal of Medicine February 2000, 67 (2) 120-127;

    Prompt diagnosis and treatment can prolong the patient’s life and improve the quality of his or her remaining days.

  • Are strict vegetarians at risk of vitamin B<sub>12</sub> deficiency?
    You have access
    Are strict vegetarians at risk of vitamin B12 deficiency?
    Margareta Novy, MPH, RD, LD
    Cleveland Clinic Journal of Medicine February 2000, 67 (2) 87;

    Patients who avoid or limit animal products in their diets should be encouraged to take vitamin B12 supplements or eat fortified foods.

Pages

  • Previous
  • Next
  • 1
  • …
  • 421
  • 422
  • 423
  • 424
  • 425
  • 426
  • 427
  • 428
  • 429
  • …
  • 799

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire